From listening to action: Turning medical insights into patient impact

Manuel Möller, vice president, Veeva Insights Strategy, Veeva Systems explores turning medical insights into patient impact.

Biopharma has never generated more data, more innovation, or more scientific exchange. Yet, despite being one of the most valuable assets for improving patient outcomes, medical insights from the field remain underused.

The industry is facing a structural paradox. Breakthrough therapies are becoming more complex and targeted, but bringing them to market is slower, more expensive, and more uncertain. Up to 90% of medicines that enter clinical development…